vs

Side-by-side financial comparison of Ivanhoe Electric Inc. (IE) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.

PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $896.0K, roughly 1.5× Ivanhoe Electric Inc.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -4500.4%, a 4082.5% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -32.7%). PLUS THERAPEUTICS, INC. produced more free cash flow last quarter ($-6.3M vs $-25.7M). Over the past eight quarters, Ivanhoe Electric Inc.'s revenue compounded faster (57.8% CAGR vs -9.7%).

Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...

IE vs PSTV — Head-to-Head

Bigger by revenue
PSTV
PSTV
1.5× larger
PSTV
$1.4M
$896.0K
IE
Growing faster (revenue YoY)
PSTV
PSTV
+29.5% gap
PSTV
-3.2%
-32.7%
IE
Higher net margin
PSTV
PSTV
4082.5% more per $
PSTV
-417.9%
-4500.4%
IE
More free cash flow
PSTV
PSTV
$19.5M more FCF
PSTV
$-6.3M
$-25.7M
IE
Faster 2-yr revenue CAGR
IE
IE
Annualised
IE
57.8%
-9.7%
PSTV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IE
IE
PSTV
PSTV
Revenue
$896.0K
$1.4M
Net Profit
$-40.3M
$-5.7M
Gross Margin
69.5%
Operating Margin
-4167.7%
-420.0%
Net Margin
-4500.4%
-417.9%
Revenue YoY
-32.7%
-3.2%
Net Profit YoY
-318.3%
-46.4%
EPS (diluted)
$0.24
$0.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IE
IE
PSTV
PSTV
Q4 25
$896.0K
$1.4M
Q3 25
$545.0K
$1.4M
Q2 25
$1.1M
$1.4M
Q1 25
$735.0K
$1.1M
Q4 24
$1.3M
$1.4M
Q3 24
$671.0K
$1.5M
Q2 24
$538.0K
$1.3M
Q1 24
$360.0K
$1.7M
Net Profit
IE
IE
PSTV
PSTV
Q4 25
$-40.3M
$-5.7M
Q3 25
$-17.5M
$-4.4M
Q2 25
$-23.9M
$5.2M
Q1 25
$-34.1M
$-17.4M
Q4 24
$18.5M
$-3.9M
Q3 24
$-43.2M
$-2.9M
Q2 24
$-46.8M
$-2.9M
Q1 24
$-60.1M
$-3.3M
Gross Margin
IE
IE
PSTV
PSTV
Q4 25
69.5%
Q3 25
51.2%
Q2 25
72.5%
Q1 25
60.1%
Q4 24
64.7%
Q3 24
61.8%
Q2 24
64.3%
Q1 24
72.2%
Operating Margin
IE
IE
PSTV
PSTV
Q4 25
-4167.7%
-420.0%
Q3 25
-4328.3%
-320.8%
Q2 25
-2400.3%
-110.6%
Q1 25
-3674.0%
-333.9%
Q4 24
-2229.4%
-276.2%
Q3 24
-6233.8%
-260.9%
Q2 24
-9023.4%
-289.1%
Q1 24
-15800.3%
-196.7%
Net Margin
IE
IE
PSTV
PSTV
Q4 25
-4500.4%
-417.9%
Q3 25
-3214.9%
-316.6%
Q2 25
-2233.2%
370.6%
Q1 25
-4645.0%
-1643.2%
Q4 24
1386.6%
-276.4%
Q3 24
-6443.5%
-197.4%
Q2 24
-8695.7%
-229.9%
Q1 24
-16693.1%
-194.5%
EPS (diluted)
IE
IE
PSTV
PSTV
Q4 25
$0.24
$0.95
Q3 25
$0.13
$-0.04
Q2 25
$0.18
$-0.01
Q1 25
$0.24
$-1.19
Q4 24
$-0.14
$-0.51
Q3 24
$0.36
$-0.37
Q2 24
$0.39
$-0.71
Q1 24
$0.46
$-0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IE
IE
PSTV
PSTV
Cash + ST InvestmentsLiquidity on hand
$173.3M
$8.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.1M
$4.0M
Total Assets
$483.3M
$16.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IE
IE
PSTV
PSTV
Q4 25
$173.3M
$8.6M
Q3 25
$69.5M
$16.6M
Q2 25
$88.0M
$6.9M
Q1 25
$98.2M
$9.9M
Q4 24
$41.0M
$3.6M
Q3 24
$81.1M
$4.8M
Q2 24
$133.8M
$8.4M
Q1 24
$179.4M
$3.2M
Stockholders' Equity
IE
IE
PSTV
PSTV
Q4 25
$416.1M
$4.0M
Q3 25
$280.1M
$5.1M
Q2 25
$293.3M
$3.0M
Q1 25
$307.0M
$-23.6M
Q4 24
$268.6M
$-8.9M
Q3 24
$250.1M
$-5.2M
Q2 24
$289.2M
$-7.6M
Q1 24
$331.5M
$-4.8M
Total Assets
IE
IE
PSTV
PSTV
Q4 25
$483.3M
$16.3M
Q3 25
$386.2M
$18.7M
Q2 25
$400.5M
$10.3M
Q1 25
$414.4M
$12.1M
Q4 24
$374.9M
$6.6M
Q3 24
$375.4M
$7.0M
Q2 24
$416.3M
$11.2M
Q1 24
$461.2M
$5.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IE
IE
PSTV
PSTV
Operating Cash FlowLast quarter
$-25.7M
$-6.3M
Free Cash FlowOCF − Capex
$-25.7M
$-6.3M
FCF MarginFCF / Revenue
-2872.8%
-459.9%
Capex IntensityCapex / Revenue
4.1%
2.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-90.6M
$-20.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IE
IE
PSTV
PSTV
Q4 25
$-25.7M
$-6.3M
Q3 25
$-27.7M
$-2.5M
Q2 25
$-20.0M
$-5.8M
Q1 25
$-15.8M
$-6.2M
Q4 24
$-30.7M
$-1.2M
Q3 24
$-36.9M
$-3.7M
Q2 24
$-44.5M
$-1.1M
Q1 24
$-50.0M
$-4.5M
Free Cash Flow
IE
IE
PSTV
PSTV
Q4 25
$-25.7M
$-6.3M
Q3 25
$-27.8M
$-2.6M
Q2 25
$-21.3M
$-5.8M
Q1 25
$-15.8M
$-6.2M
Q4 24
$-32.4M
$-1.2M
Q3 24
$-36.9M
$-3.7M
Q2 24
$-45.0M
$-1.2M
Q1 24
$-50.6M
$-4.6M
FCF Margin
IE
IE
PSTV
PSTV
Q4 25
-2872.8%
-459.9%
Q3 25
-5103.9%
-184.3%
Q2 25
-1990.1%
-417.6%
Q1 25
-2146.5%
-583.1%
Q4 24
-2432.4%
-86.5%
Q3 24
-5506.6%
-253.7%
Q2 24
-8372.9%
-96.2%
Q1 24
-14064.2%
-271.5%
Capex Intensity
IE
IE
PSTV
PSTV
Q4 25
4.1%
2.2%
Q3 25
16.9%
1.9%
Q2 25
117.6%
0.5%
Q1 25
0.3%
0.3%
Q4 24
127.3%
0.8%
Q3 24
8.8%
1.0%
Q2 24
93.7%
6.3%
Q1 24
186.7%
2.4%
Cash Conversion
IE
IE
PSTV
PSTV
Q4 25
Q3 25
Q2 25
-1.13×
Q1 25
Q4 24
-1.66×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons